Free Trial

USANA Health Sciences (USNA) Earnings Date, Estimates & Call Transcripts

USANA Health Sciences logo
$39.52 +0.48 (+1.23%)
(As of 11/20/2024 ET)

USANA Health Sciences Latest Earnings Summary

Upcoming Q4
Earnings Date
Feb. 4Estimated
Actual EPS
(Oct. 22)
$0.56 Beat By $0.07
Consensus EPS
(Oct. 22)
$0.49

USANA Health Sciences announced Q3 2024 earnings on October 22, 2024, reporting an EPS of $0.56, which beat the consensus estimate of $0.49 by $0.07. Quarterly revenue was reported to be $200.22 million, below the consensus estimate of $208.45 million. With a trailing EPS of $2.83 and a P/E Ratio of 13.96, USANA Health Sciences' earnings are expected to grow 1.63% next year, from $2.45 to $2.49 per share.

USNA Upcoming Earnings

USANA Health Sciences' next earnings date is estimated for Tuesday, February 4, 2025, based off prior year's reporting schedules.

Get USANA Health Sciences Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on USANA Health Sciences and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

USNA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

USNA Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

USANA Health Sciences Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20242$0.63$0.75$0.69 
Q2 20242$0.62$0.68$0.65 
Q3 20242$0.46$0.51$0.49 
Q4 20242$0.49$0.49$0.49 
FY 20248$2.20$2.43$2.32 
Q1 20251$0.73$0.73$0.73 
Q2 20251$0.61$0.61$0.61 
Q3 20251$0.64$0.64$0.64 
Q4 20251$0.75$0.75$0.75 
FY 20254$2.73$2.73$2.73 
Q1 20261$0.82$0.82$0.82 
Q2 20261$0.74$0.74$0.74 
Q3 20261$0.77$0.77$0.77 

USANA Health Sciences Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
2/4/2025
(Estimated)
------- 
10/22/2024Q3 2024$0.49$0.56+$0.07$0.56$208.45M$200.22M        
7/23/2024Q2 2024$0.65$0.54 -$0.11$0.54$218.64M$212.87M      
4/30/2024Q1 2024$0.69$0.86+$0.17$0.86$223.27M$227.80M    
2/6/2024Q4 2023$0.52$0.87+$0.35$0.87$206.70M$221.08M  
10/24/2023Q3 2023$0.64$0.59 -$0.05$0.59$212.24M$213.37M      
7/25/2023Q2 2023$0.70$0.89+$0.19$0.89$224.77M$238.20M      
4/25/2023Q1 2023$0.77$0.95+$0.18$0.95-$248.36M  
2/7/2023Q4 2022$0.35$0.66+$0.31$0.66-$227.96M        

USANA Health Sciences Earnings - Frequently Asked Questions

USANA Health Sciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 4th, 2025 based off last year's report dates. Learn more on USNA's earnings history.

USANA Health Sciences updated its FY 2024 earnings guidance on Tuesday, October, 22nd. The company provided earnings per share guidance of 2.450-2.450 for the period, compared to the consensus earnings per share estimate of 2.500. The company issued revenue guidance of $850.0 million-$850.0 million, compared to the consensus revenue estimate of $861.9 million.

In the previous quarter, USANA Health Sciences (NYSE:USNA) reported $0.56 earnings per share (EPS) to beat the analysts' consensus estimate of $0.49 by $0.07. Learn more on analysts' earnings estimate vs. USNA's actual earnings.

The conference call for USANA Health Sciences's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for USANA Health Sciences's latest earnings report can be read online.
Read Transcript

USANA Health Sciences (NYSE:USNA) has a recorded annual revenue of $921.01 million.

USANA Health Sciences (NYSE:USNA) has a recorded net income of $63.79 million. USNA has generated $2.83 earnings per share over the last four quarters.

USANA Health Sciences (NYSE:USNA) has a trailing price-to-earnings ratio of 13.96 and a forward price-to-earnings ratio of 16.13. The price/earnings-to-growth ratio is 1.33.

USANA Health Sciences's earnings are expected to grow from $2.45 per share to $2.49 per share in the next year, which is a 1.63% increase.

`

More Earnings Resources from MarketBeat



This page (NYSE:USNA) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners